Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial assessing filgrastim with chemotherapy followed by peripheral stem cell transplant in Hodgkin lymphoma and Non-Hodgkin lymphom…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating biological therapies following peripheral stem cell transplantation in patients with non-Hodgkin lymphoma,…
-
CLINICAL_TRIALS withdrawal · 2017-11-29Clinical Trial Update: Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 2]
Phase 2 trial evaluating specially treated stem cells for peripheral stem cell transplantation in patients with Non-Hodgkin lymphoma or Hodg…
-
CLINICAL_TRIALS research · 2017-11-24Clinical Trial Update: Italian Multicenter Retrospective Observational Study on Transformed Lymphomas
An Italian multicenter retrospective observational study on transformed non-Hodgkin lymphoma, with the study status currently unknown.
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
This Phase 2 trial evaluated the combination of Rituximab with Yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with Non-Hodgkin lympho…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-11-20Clinical Trial Update: A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199 [Phase 1]
Phase 1 pharmacokinetic study to assess how ketoconazole affects the metabolism of venetoclax (ABT-199) in patients with Non-Hodgkin lymphom…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma [Phase 2]
This Phase 2 trial evaluated the combination of vorinostat, cladribine, and rituximab in patients with mantle cell lymphoma, relapsed chroni…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant [Phase 2]
Phase 2 trial evaluating whether Fludeoxyglucose F-18 PET can predict relapse risk in Non-Hodgkin lymphoma patients undergoing combination c…
-
FDA approval · 2017-11-03FDA Approved: DOXORUBICIN HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for doxorubicin hydrochloride from BluePoint Laboratories, adding a new approved generic version of …
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]
This Phase 2 study evaluated a conditioning regimen combining chemotherapy, total-body irradiation, and rituximab followed by donor stem cel…
-
CLINICAL_TRIALS research · 2017-10-24Clinical Trial Update: Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy [Phase 2]
A Phase 2 clinical trial evaluates the combination of Rituximab with autologous effector lymphocytes in follicular lymphoma patients respond…
-
CLINICAL_TRIALS trial_result · 2017-10-23Clinical Trial Update: Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630) [Phase 1]
A Phase 1 study evaluating every-3-week dosing of SCH 727965 in patients with advanced cancer (including Non-Hodgkin lymphoma and multiple m…
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: A Phase II Study for Patients With Indolent Non-follicular Non-Hodgkin's Lymphoma [Phase 2]
A Phase II trial for indolent non-follicular non-Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of iodine-131–labeled monoclonal antibody BC8 used before autologous stem cell transplant in relapsed or refractory Hodgkin ly…
-
CLINICAL_TRIALS trial_result · 2017-10-11Clinical Trial Update: Phase I/II Study of Escalating Doses of Idarubicin Orally Given With Oral Cyclophosphamide, Etoposide, Prednisolone and Intravenous Rituximab in Elderly Patient With Disseminated High Grade Non Hodgkin Lymphoma [Phase 1, Phase 2]
Phase I/II trial evaluating escalating oral idarubicin with cyclophosphamide, etoposide, prednisolone and intravenous rituximab in elderly p…
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma [Phase 2]
This Phase 2 trial assessed safety and efficacy of rituximab combined with interleukin-2 in high-risk non-Hodgkin lymphoma; the study has co…
-
CLINICAL_TRIALS trial_result · 2017-10-04Clinical Trial Update: PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment [Phase 1]
Phase 1 trial of PU-H71 in patients with solid tumors and low-grade non-Hodgkin's lymphoma that failed standard therapy; study terminated wi…
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial update for CAT-8015 in children and young adults with acute lymphoblastic leukemia or non-Hodgkin's lymphoma; study completed …
-
CLINICAL_TRIALS trial_result · 2017-09-12Clinical Trial Update: Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma [Phase 2]
A Phase II clinical trial evaluating the RT-PEPC regimen in relapsed mantle cell lymphoma has completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma [Phase 1]
A Phase 1 study evaluating the safety of combining ibrutinib with rituximab and CHOP chemotherapy in CD20-positive B-cell non-Hodgkin lympho…
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating Velcade (bortezomib) and temsirolimus for relapsed or refractory non-Hodgkin lymphoma has completed with results po…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas [Phase 2]
Phase 2 study evaluating liposomal doxorubicin (Doxil) in combination with rituximab, cyclophosphamide, vincristine and prednisone for newly…
-
CLINICAL_TRIALS research · 2017-08-10Clinical Trial Update: Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation [Phase 2]
A Phase 2 trial is evaluating low-dose plerixafor plus G-CSF to mobilize stem cells for autologous peripheral blood transplantation in lymph…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant [Phase 2]
Phase 2 clinical trial update assessing safety and tolerability of HSC835 in patients with hematological malignancies undergoing single umbi…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies [Phase 2]
This Phase 2 randomized trial comparing haplo cord blood transplantation versus double umbilical cord blood transplantation for hematologic …